Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2007-1-15
pubmed:abstractText
This study examined whether glial cells in the trigeminal nucleus caudalis (Sp5C) were necessary for orofacial nociception and nociceptive processing induced by subcutaneously (s.c.) injection of 5% formalin into left mystacial vibrissae. The immunohistochemical, immunoelectron microscopical methods and behavior assessment were used in this study. Two hours after administration of carbenoxolone (CBX, a gap junction blocker) or fluorocistrate (FCA, a glail metabolic inhibitor) into the cerebellomedullary cistern, the nociceptive behavior and scratching-cumulative time reduced significantly (P<0.01). FCA attenuated obviously the expression of Fos/NeuN-immunoreactive (-IR) neurons (mean+/-S.E.M.=29+/-2.5) and Fos/glial fibrillary acidic protein (GFAP)-IR astrocytes (7.2+/-2.2) in Sp5C. CBX decreased the number of Fos/NeuN-IR neurons (25+/-1.7), but did not affect Fos/GFAP-IR astrocytes (16.2+/-5.4), compared with vehicle-preadministered rats (Fos/NeuN-IR neurons 135+/-4.2, and Fos/GFAP-IR astrocytes 25.8+/-4). Immunoelectron microscopy established that Cx32/Cx43 heterotypic gap junctions (HGJs) were present on junction areas between astrocytes and neurons within Sp5C. The number of HGJs increased significantly following formalin s.c. injection. It suggests that the Sp5C astrocytes may play an active regulating role in orofacial nociception via Cx32/Cx43 HGJs between astrocytes and neurons of Sp5C.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0168-0102
pubmed:author
pubmed:issnType
Print
pubmed:volume
57
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
112-9
pubmed:meshHeading
pubmed-meshheading:17184865-Animals, pubmed-meshheading:17184865-Behavior, Animal, pubmed-meshheading:17184865-Carbenoxolone, pubmed-meshheading:17184865-Citrates, pubmed-meshheading:17184865-Disease Models, Animal, pubmed-meshheading:17184865-Drug Interactions, pubmed-meshheading:17184865-Fluorescent Antibody Technique, pubmed-meshheading:17184865-Formaldehyde, pubmed-meshheading:17184865-Gap Junctions, pubmed-meshheading:17184865-Gene Expression Regulation, pubmed-meshheading:17184865-Glial Fibrillary Acidic Protein, pubmed-meshheading:17184865-Male, pubmed-meshheading:17184865-Microscopy, Immunoelectron, pubmed-meshheading:17184865-Neuroglia, pubmed-meshheading:17184865-Oncogene Proteins v-fos, pubmed-meshheading:17184865-Pain Measurement, pubmed-meshheading:17184865-Phosphopyruvate Hydratase, pubmed-meshheading:17184865-Rats, pubmed-meshheading:17184865-Rats, Sprague-Dawley, pubmed-meshheading:17184865-Skin, pubmed-meshheading:17184865-Trigeminal Neuralgia, pubmed-meshheading:17184865-Trigeminal Nuclei
pubmed:year
2007
pubmed:articleTitle
Blocking the glial function suppresses subcutaneous formalin-induced nociceptive behavior in the rat.
pubmed:affiliation
Institute of Neurosciences, The Fourth Military Medical University, Changle West Road, Xi'an 710032, PR China.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't